Literature DB >> 24599987

Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database.

Linda M Kampschreur1, Corine E Delsing, Rolf H H Groenwold, Marjolijn C A Wegdam-Blans, Chantal P Bleeker-Rovers, Monique G L de Jager-Leclercq, Andy I M Hoepelman, Marjo E van Kasteren, Jacqueline Buijs, Nicole H M Renders, Marrigje H Nabuurs-Franssen, Jan Jelrik Oosterheert, Peter C Wever.   

Abstract

Coxiella burnetii causes Q fever, a zoonosis, which has acute and chronic manifestations. From 2007 to 2010, the Netherlands experienced a large Q fever outbreak, which has offered a unique opportunity to analyze chronic Q fever cases. In an observational cohort study, baseline characteristics and clinical characteristics, as well as mortality, of patients with proven, probable, or possible chronic Q fever in the Netherlands, were analyzed. In total, 284 chronic Q fever patients were identified, of which 151 (53.7%) had proven, 64 (22.5%) probable, and 69 (24.3%) possible chronic Q fever. Among proven and probable chronic Q fever patients, vascular infection focus (56.7%) was more prevalent than endocarditis (34.9%). An acute Q fever episode was recalled by 27.0% of the patients. The all-cause mortality rate was 19.1%, while the chronic Q fever-related mortality rate was 13.0%, with mortality rates of 9.3% among endocarditis patients and 18% among patients with a vascular focus of infection. Increasing age (P=0.004 and 0.010), proven chronic Q fever (P=0.020 and 0.002), vascular chronic Q fever (P=0.024 and 0.005), acute presentation with chronic Q fever (P=0.002 and P<0.001), and surgical treatment of chronic Q fever (P=0.025 and P<0.001) were significantly associated with all-cause mortality and chronic Q fever-related mortality, respectively.

Entities:  

Mesh:

Year:  2014        PMID: 24599987      PMCID: PMC3993626          DOI: 10.1128/JCM.03221-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Chronic Q fever: expert opinion versus literature analysis and consensus.

Authors:  Didier Raoult
Journal:  J Infect       Date:  2012-04-23       Impact factor: 6.072

3.  Risks factors and prevention of Q fever endocarditis.

Authors:  F Fenollar; P E Fournier; M P Carrieri; G Habib; T Messana; D Raoult
Journal:  Clin Infect Dis       Date:  2001-06-25       Impact factor: 9.079

4.  Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections.

Authors:  D Raoult; H Tissot-Dupont; C Foucault; J Gouvernet; P E Fournier; E Bernit; A Stein; M Nesri; J R Harle; P J Weiller
Journal:  Medicine (Baltimore)       Date:  2000-03       Impact factor: 1.889

5.  Follow-up of 686 patients with acute Q fever and detection of chronic infection.

Authors:  Wim van der Hoek; Bart Versteeg; Jamie C E Meekelenkamp; Nicole H M Renders; Alexander C A P Leenders; Ineke Weers-Pothoff; Mirjam H A Hermans; Hans L Zaaijer; Peter C Wever; Peter M Schneeberger
Journal:  Clin Infect Dis       Date:  2011-06-15       Impact factor: 9.079

6.  Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection.

Authors:  F Fenollar; P E Fournier; D Raoult
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 7.  Q fever.

Authors:  M Maurin; D Raoult
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

8.  Coxiella burnetii blood cultures from acute and chronic Q-fever patients.

Authors:  D Musso; D Raoult
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Q fever serology: cutoff determination for microimmunofluorescence.

Authors:  H T Dupont; X Thirion; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

10.  Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak.

Authors:  L M Kampschreur; J C J P Hagenaars; C C H Wielders; P Elsman; P J Lestrade; O H J Koning; J J Oosterheert; N H M Renders; P C Wever
Journal:  Epidemiol Infect       Date:  2012-06-13       Impact factor: 4.434

View more
  31 in total

1.  Coxiella burnetii RpoS Regulates Genes Involved in Morphological Differentiation and Intracellular Growth.

Authors:  Derek E Moormeier; Kelsi M Sandoz; Paul A Beare; Daniel E Sturdevant; Vinod Nair; Diane C Cockrell; Heather E Miller; Robert A Heinzen
Journal:  J Bacteriol       Date:  2019-03-26       Impact factor: 3.490

Review 2.  Right on Q: genetics begin to unravel Coxiella burnetii host cell interactions.

Authors:  Charles L Larson; Eric Martinez; Paul A Beare; Brendan Jeffrey; Robert A Heinzen; Matteo Bonazzi
Journal:  Future Microbiol       Date:  2016-07-15       Impact factor: 3.165

3.  Comparison of Different Commercially Available Enzyme-Linked Immunosorbent Assays with Immunofluorescence Test for Detection of Phase II IgG and IgM Antibodies to Coxiella burnetii.

Authors:  Larissa Dangel; Daniela Koempf; Silke F Fischer
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

Review 4.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 5.  Coxiella burnetii: international pathogen of mystery.

Authors:  Amanda L Dragan; Daniel E Voth
Journal:  Microbes Infect       Date:  2019-09-28       Impact factor: 2.700

6.  Dysregulation of serum gamma interferon levels in vascular chronic Q Fever patients provides insights into disease pathogenesis.

Authors:  Jeroen L A Pennings; Marjolein N T Kremers; Hennie M Hodemaekers; Julia C J P Hagenaars; Olivier H J Koning; Nicole H M Renders; Mirjam H A Hermans; Arja de Klerk; Daan W Notermans; Peter C Wever; Riny Janssen
Journal:  Clin Vaccine Immunol       Date:  2015-04-29

7.  Circulation of Coxiella burnetii in a Naturally Infected Flock of Dairy Sheep: Shedding Dynamics, Environmental Contamination, and Genotype Diversity.

Authors:  A Joulié; K Laroucau; X Bailly; M Prigent; P Gasqui; E Lepetitcolin; B Blanchard; E Rousset; K Sidi-Boumedine; E Jourdain
Journal:  Appl Environ Microbiol       Date:  2015-08-07       Impact factor: 4.792

8.  Should Acute Q-Fever Patients be Screened for Valvulopathy to Prevent Endocarditis?

Authors:  Marit M A de Lange; Laura E V Gijsen; Cornelia C H Wielders; Wim van der Hoek; Arko Scheepmaker; Peter M Schneeberger
Journal:  Clin Infect Dis       Date:  2018-07-18       Impact factor: 9.079

9.  Surveillance for Q Fever Endocarditis in the United States, 1999-2015.

Authors:  Anne Straily; F Scott Dahlgren; Amy Peterson; Christopher D Paddock
Journal:  Clin Infect Dis       Date:  2017-11-13       Impact factor: 9.079

10.  Fluorescence In Situ Hybridization (FISH) and Peptide Nucleic Acid Probe-Based FISH for Diagnosis of Q Fever Endocarditis and Vascular Infections.

Authors:  Elsa Prudent; Hubert Lepidi; Emmanouil Angelakis; Didier Raoult
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 11.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.